Dan Lowrie Appointed as CEO of Imedex to Lead Next Phase of Innovation and Growth

Share Article

Appointment Caps a Year of Successful Transition Since Acquisition By Vesey Street Capital Partners LLC

Imedex
I am excited to join Imedex at a time when it is transforming the future of CME by investing in innovations to meet the evolving needs of clinicians.

Imedex, LLC, the leading global provider of accredited, independent Continuing Medical Education, today announced the appointment of Dan Lowrie as Chief Executive Officer to lead the next phase of the company’s long-term growth strategy.

The appointment comes a year after Imedex was acquired by Vesey Street Capital Partners LLC (VSCP), and completes a successful transition into an independent business including the expansion of the company’s online portfolio and the launch of a new e-learning platform.

Lowrie joins Imedex from MedAssets, where he oversaw the growth of its supply chain software portfolio as Senior Vice President, Spend Operations. Andy Schutt, who served as Imedex CEO since the VSCP acquisition, will become President and Chief Financial Officer and continue to serve on the company’s Board of Directors.

“Dan’s appointment is part of our ongoing investment in expanding Imedex’s leadership so we can provide the most relevant and innovative continuing education for clinicians,” said Steve Geringer, Imedex chairman. “Dan has a proven track record of adapting businesses to meet customer needs in an increasingly digital world. With Dan and the rest of the leadership team, Imedex is well-positioned to bring new innovation and services to our customers.”

During the last year, Imedex has taken steps to bolster its core business while identifying new growth opportunities, resulting in extending its industry-leading clinical conferences, expanding its e-learning curriculum and participation, and capitalizing on its excellence in accreditation to certify other third-party education.

“I am excited to join Imedex at a time when it is transforming the future of CME by investing in innovations to meet the evolving needs of clinicians,” Lowrie said. “Imedex is in a strong position to continue adding depth in the therapy domains we currently lead, while investing in additional areas of medicine and expanding our global footprint.”

“We continue to be very excited about expansion opportunities in the accredited CME industry. Imedex was a successful platform acquisition and we will continue to focus on deploying capital in growth initiatives,” said Adam Feinstein, Founder and General Partner at VSCP. “Dan is an exceptional leader with substantial experience in driving growth and building businesses. He is the ideal executive to take Imedex to the next level and will be a great steward of the trusted Imedex brand name.”

Lowrie brings a range of leadership practice from his time at MedAssets including experience in operations, technology, corporate development, and incubation. Prior to MedAssets, he held consulting positions at Oliver Wyman. He holds a Master of Business Administration degree from The Wharton School at the University of Pennsylvania and a Bachelor’s degree from Duke University.

About Imedex®
Imedex is a global industry leader in providing certified, independent continuing medical education to healthcare professionals. We develop high-quality, scientific live and online programming that translates the latest research into clinically-relevant learning for physicians and clinical professionals. Our programs deliver outstanding educational value with a proven sustained impact on disease management and patient outcomes. With more than 50,000 e-learning experiences annually and more than 100,000 live meeting participants since 2001, Imedex educates the global healthcare community. At Imedex, education is the best medicine.® For more information on Imedex, visit our e-learning center at http://elc.imedex.com and our website at http://www.imedex.com.

About Vesey Street Capital Partners LLC
Vesey Street Capital Partners (VSCP) is a strategic private equity firm with an expertise in healthcare services. Our focused strategy is centered upon investing primarily in founder owned businesses and corporate carve-outs that create value for hospitals, physicians, and payors by enhancing operating efficiencies, improving quality of care, reducing costs and increasing revenue. We create value for portfolio companies by leveraging our strategic LP base of healthcare executives and family offices. VSCP was founded in 2014 and currently has three portfolio companies, including ScribeAmerica, Imedex and Pathgroup. For more information on Vesey Street Capital Partners, visit http://www.vscpllc.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cortney Bailey
Imedex
+1 6782420930
Email >
@ImedexCME
Follow >
Imedex, LLC
since: 06/2011
Like >
Imedex

Visit website